Doximity, Inc. (NASDAQ:DOCS) Given Average Rating of “Hold” by Analysts

Shares of Doximity, Inc. (NASDAQ:DOCSGet Free Report) have earned an average recommendation of “Hold” from the fourteen ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $28.82.

A number of equities analysts have recently commented on the company. Bank of America raised their price target on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a report on Tuesday, January 23rd. Wells Fargo & Company raised their price target on Doximity from $25.00 to $27.00 and gave the stock an “equal weight” rating in a report on Friday, February 9th. SVB Leerink assumed coverage on Doximity in a report on Monday, February 26th. They issued a “market perform” rating and a $32.00 price target for the company. JPMorgan Chase & Co. raised their price target on Doximity from $22.00 to $25.00 and gave the stock an “underweight” rating in a report on Friday, March 15th. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $30.00 price target on shares of Doximity in a report on Tuesday, April 2nd.

View Our Latest Report on DOCS

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the sale, the director now owns 10,258 shares in the company, valued at $276,658.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 39.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Doximity

A number of large investors have recently added to or reduced their stakes in DOCS. Bank of New York Mellon Corp raised its position in Doximity by 60.6% during the first quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company’s stock valued at $9,004,000 after purchasing an additional 65,196 shares in the last quarter. US Bancorp DE raised its position in Doximity by 325.4% during the first quarter. US Bancorp DE now owns 2,646 shares of the company’s stock valued at $138,000 after purchasing an additional 2,024 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its position in Doximity by 417.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company’s stock valued at $1,099,000 after purchasing an additional 17,021 shares in the last quarter. Natixis Advisors L.P. purchased a new stake in Doximity during the first quarter valued at about $983,000. Finally, BlackRock Inc. grew its stake in shares of Doximity by 53.6% during the first quarter. BlackRock Inc. now owns 2,052,183 shares of the company’s stock valued at $106,898,000 after buying an additional 716,547 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Trading Down 0.8 %

Shares of NASDAQ DOCS opened at $24.63 on Friday. The stock has a fifty day simple moving average of $27.53 and a two-hundred day simple moving average of $26.13. Doximity has a 1-year low of $19.71 and a 1-year high of $37.06. The firm has a market cap of $4.59 billion, a price-to-earnings ratio of 37.32, a price-to-earnings-growth ratio of 3.12 and a beta of 1.17.

Doximity (NASDAQ:DOCSGet Free Report) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The business had revenue of $135.28 million during the quarter, compared to analyst estimates of $127.46 million. Analysts forecast that Doximity will post 0.72 EPS for the current year.

Doximity Company Profile

(Get Free Report

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.